March Biosciences has filed a notice of an exempt offering of securities to raise $22,140,942.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, March Biosciences is raising up to $22,140,942.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…